PubMed ID: 39029105 Author(s): Elwood KF, Warner EJ, Chang JS, Kopplin LJ. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR. Retin Cases Brief Rep. 2024 Jul 19. doi: 10.1097/ICB.0000000000001633. Online ahead of print. …
Evan Warner
A rare case of acantholytic squamous cell carcinoma presenting on non-sun exposed palpebral conjunctiva.
PubMed ID: 38975032 Author(s): Jain AS, Duncan NB, Potter HD, Burkat CN, Warner EJ. A rare case of acantholytic squamous cell carcinoma presenting on non-sun exposed palpebral conjunctiva. Am J Ophthalmol Case Rep. 2024 Jun …
Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease.
PubMed ID: 38625674 Author(s): Maganti N, Whittier SA, Warner EJ. Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease. J Ophthalmic Inflamm Infect. 2024 Apr 16;14(1):15. …
Laser in Situ Keratomileusis Flap Free-Floating on Interface Edema in Acute Corneal Hydrops.
PubMed ID: 38512159 Author(s): Warner EJ. Laser in Situ Keratomileusis Flap Free-Floating on Interface Edema in Acute Corneal Hydrops. JAMA Ophthalmol. 2024 Mar 1;142(3):e234806. doi: 10.1001/jamaophthalmol.2023.4806. Epub 2024 Mar 21. PMID 38512159 Journal: Jama Ophthalmology, …
NEXPEDE-1
A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2/3 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1).
KOWA 303
A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD).
KOWA 301
A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD).
Cystic Focal Ectasia Due to Moraxella Keratitis Identified in Formalin-Fixed Tissue.
PubMed ID: 37715778 Author(s): Warner EJ, Bradfield YS, Shatten J. Cystic Focal Ectasia Due to Moraxella Keratitis Identified in Formalin-Fixed Tissue. Ophthalmology. 2023 Sep 14:S0161-6420(23)00615-2. doi: 10.1016/j.ophtha.2023.08.018. Online ahead of print. No abstract available. PMID …
Cystic Focal Ectasia Due to Moraxella Keratitis Identified in Formalin-Fixed Tissue.
PubMed ID: 37715778 Author(s): Warner EJ, Bradfield YS, Shatten J. Cystic Focal Ectasia Due to Moraxella Keratitis Identified in Formalin-Fixed Tissue. Ophthalmology. 2023 Sep 14:S0161-6420(23)00615-2. doi: 10.1016/j.ophtha.2023.08.018. Online ahead of print. No abstract available. PMID …